Use of Continuous Glucose Monitors in Children and Adolescents With Obesity

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of California, Los Angeles
Study ID
NCT06254768
Status
Recruiting
Apply to this trial

Conditions

  • Pediatric Obesity

Eligibility Criteria

Sex
ALL
Age
10 Years - 21 Years
Healthy Volunteers
Accepted

Interventions

  • Continuous glucose monitor — DEVICE
    its a device used to measure glucose from interstitial fluids and provides feedback regarding the same every 5 minutes.

Study Details

To study if continuous glucose monitors are feasible for use in children and adolescents with obesity.

Key Dates

Start date
Jan 17, 2023
Status verified
Feb 2024
Primary completion
Mar 31, 2024
Completion
Jun 30, 2024

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION

Arms

  • Experimental: Unblinded
    They will wear the device and have access to their data- UNBLINDED ARM
  • Experimental: Blinded
    They will wear the device but will not have access to their data- BLINDED ARM

Primary Outcome Measure

Feasibility of continuous glucose monitor(CGM) use in children and adolescents with obesity [ Time Frame: 6 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Pediatric Endocrinology Division, University of CaliforniaLos AngelesCalifornia90025
Sri Nikhita Chimatapu
[email protected]
917-741-4080

Find similar trials in Los Angeles, CA

By research site
Pediatric Endocrinology Division, University of California· Los Angeles, CA

Related Studies